on 16 September 2026, robot-themed shares traded in a range, while HUAYAN ROBOTICS (01021.HK) strengthened. As of 15:15, the company quoted HKD 11.110, up 12.00%.
On September 16, 2026, RoboSense (02498.HK) edged higher in the afternoon. As of 14:03, the stock was quoted at HK$16.16, up 1.32%.
on 16 September 2026, AI chip stocks strengthened, with SMIC (00981.HK) strengthening as well. As of 13:36, the company quoted HKD 63.200, up 4.03%.
on 16 September 2026, humanoid robot stocks traded actively while UBTECH ROBOTICS (09880.HK) strengthened. As of 13:25, the company quoted HKD 77.550, up 1.11%.
On 16 September 2026, YESTAR HEALTH (02393.HK) published its interim report, with revenue down 17.6% to RMB 661.6 million, gross profit up 8.3% and a loss of RMB 479,000, with no interim dividend declared.
On 15 September 2026, HENGRUI PHARMA (01276.HK) announced that its subsidiary Guangdong Hengrui Pharmaceuticals received a Drug Clinical Trial Approval Notice from the NMPA approving a Phase III clinical trial of recaticimab for injection in adult patients with intracranial atherosclerotic stenosis.
On 16 September 2026, SBP GROUP (01177.HK) announced that the NDA for TQH2722 injection (an IL-4Rα monoclonal antibody), a National Class 1 innovative drug independently developed by its subsidiary Chia Tai Tianqing, has been accepted for review by the CDE, for moderate-to-severe atopic dermatitis in adults.
On 15 September 2026, YUK WING GP (01536.HK) announced that controlling shareholder Choi Fai Investment disposed of an aggregate of 175,746,000 shares between 8 and 15 September 2026, representing approximately 38.54% of the Company's total issued share capital, and ceased to be a controlling and substantial shareholder.
On 16 September 2026, TRIP.COM-S (09961.HK) announced its second quarter and first half results, with second quarter net revenue of RMB 15.7 billion, up 6% year on year, and a net loss of RMB 2.4 billion because of a RMB 5.2 billion antitrust penalty.
On 15 September 2026, DTECH (01377.HK) announced that its wholly-owned subsidiary Dingtaixin will invest in and build an advanced new materials manufacturing base project in Houjie, Dongguan, with a total investment of RMB 700 million, including RMB 560 million of fixed asset investment.
On 15 September 2026, Suzhou Basecare Medical Corporation Limited (02170.HK) announced that the freezing solution kit and the thawing solution kit of its Gems vitrification series have recently obtained Class III medical device registration certificates issued by the National Medical Products Administration; the products originate from the same research and development system as the Gavi fully automated closed vitrification system.
On 15 September 2026, Jiangsu New Vision Automotive Electronics Co., Ltd. (02632.HK) announced that it is cooperating with Zhejiang University to develop ultra-high-precision computational holography key technology to develop a computer-generated holography (CGH) image generation solution for visual products and advance the application of CGH technology in visual products; the cooperation does not constitute a discloseable transaction or a connected transaction under Chapter 14 or Chapter 14A of the Listing Rules.
On 15 September 2026, PATEO CONNECT Technology (Shanghai) Corporation (02889.HK) announced that Mr. Zhang Fukai, an executive director, chief financial officer and Board Secretary, and Mr. Lai Weilin, an executive director, increased their holdings of the Company's H shares on the open market with their own funds by 40,760 shares and 21,860 shares respectively, representing approximately 0.024% and approximately 0.013% of the total issued shares, for total consideration of approximately RMB 3.00 million and approximately RMB 1.60 million respectively.
On 15 September 2026, Jolimark Holdings Limited (02028.HK) announced that the controlling shareholder completed a partial placing on that date, with the vendor placing an aggregate of 129,100,000 shares through the placing agent in accordance with the terms of the placing agreement; as the placing may or may not be carried out in full, shareholders and potential investors should exercise caution when dealing in the shares.
On 15 September 2026, KINGMAKER (01170.HK) announced that, on the recommendation of the remuneration committee, the Board resolved to grant a total of 1,292,000 award shares to 15 grantees under the share award scheme free of charge, representing approximately 0.19% of the Company's issued share capital as at the date of the announcement.
On 15 September 2026, ASIAN CITRUS (00073.HK) announced that on 14 September 2026 the Group disposed of an aggregate of 590 MSFT shares on the market through Cheer Kind at an average price of approximately USD 503.73 per share, for a total consideration of approximately USD 297,200.70 (equivalent to approximately HKD 2,320,000), constituting a discloseable transaction under the Listing Rules.
